-
Je něco špatně v tomto záznamu ?
Methotrexate released in vitro from bone cement inhibits human stem cell proliferation in S/G2 phase
E. Procházka, T. Soukup, M. Hroch, L. Fuksa, E. Brčáková, J. Cermanová, G. Kolouchová, K. Urban, J. Mokrý, S. Mičuda
Jazyk angličtina Země Německo
Typ dokumentu práce podpořená grantem
NLK
Free Medical Journals
od 1997 do 2014-03-31
PubMed Central
od 1997 do 2014
Europe PubMed Central
od 1997 do 2014
Medline Complete (EBSCOhost)
od 2007-02-01 do Před 1 rokem
- MeSH
- buňky kostní dřeně patologie účinky léků MeSH
- interfáze účinky léků MeSH
- kostní cementy chemie MeSH
- kultivované buňky MeSH
- lidé MeSH
- methotrexát aplikace a dávkování chemie MeSH
- mezenchymální kmenové buňky patologie účinky léků MeSH
- proliferace buněk účinky léků MeSH
- protinádorové antimetabolity aplikace a dávkování chemie MeSH
- viabilita buněk účinky léků MeSH
- Check Tag
- lidé MeSH
- Publikační typ
- práce podpořená grantem MeSH
Methotrexate (MTX) released from bone cement showed a useful local effect in animal models of bone tumours. However, local toxic reactions such as impaired wound healing were observed in areas surrounding the MTX-loaded implant. Therefore, we hypothesised that MTX released from bone cement would have harmful effects on human mesenchymal stem cells (MSC)-one of the basic components of bone marrow and tissue reparatory processes. Moreover, elution of MTX was calculated from implants prepared either with liquid or powdered MTX. During the 28-day incubation, the cement compounded with liquid MTX showed the highest elution rate of the drug. MTX released from pellets produced a significant decrease in proliferation of MSC as a consequence of a blockade of their cell cycle in the S/G2 phase. These findings indicate impairment of stem cell function in marginal areas surrounding the MTX-loaded cement and may help to explain problems with regeneration of tissues in these locations.
- 000
- 02907naa a2200481 a 4500
- 001
- bmc12008642
- 003
- CZ-PrNML
- 005
- 20130129164337.0
- 008
- 120316s2010 gw eng||
- 009
- AR
- 040 __
- $a ABA008 $b cze $d ABA008
- 041 0_
- $a eng
- 044 __
- $a gw
- 100 1_
- $a Procházka, Egon $7 xx0070634 $u Department of Orthopedic Surgery, Charles University in Prague, Faculty of Medicine and University Hospital in Hradec Kralove, Hradec Kralove, Czech Republic.
- 245 10
- $a Methotrexate released in vitro from bone cement inhibits human stem cell proliferation in S/G2 phase $c E. Procházka, T. Soukup, M. Hroch, L. Fuksa, E. Brčáková, J. Cermanová, G. Kolouchová, K. Urban, J. Mokrý, S. Mičuda
- 520 9_
- $a Methotrexate (MTX) released from bone cement showed a useful local effect in animal models of bone tumours. However, local toxic reactions such as impaired wound healing were observed in areas surrounding the MTX-loaded implant. Therefore, we hypothesised that MTX released from bone cement would have harmful effects on human mesenchymal stem cells (MSC)-one of the basic components of bone marrow and tissue reparatory processes. Moreover, elution of MTX was calculated from implants prepared either with liquid or powdered MTX. During the 28-day incubation, the cement compounded with liquid MTX showed the highest elution rate of the drug. MTX released from pellets produced a significant decrease in proliferation of MSC as a consequence of a blockade of their cell cycle in the S/G2 phase. These findings indicate impairment of stem cell function in marginal areas surrounding the MTX-loaded cement and may help to explain problems with regeneration of tissues in these locations.
- 590 __
- $a bohemika - dle Pubmed
- 650 02
- $a protinádorové antimetabolity $x aplikace a dávkování $x chemie $7 D000964
- 650 02
- $a kostní cementy $x chemie $7 D001843
- 650 02
- $a buňky kostní dřeně $x patologie $x účinky léků $7 D001854
- 650 02
- $a proliferace buněk $x účinky léků $7 D049109
- 650 02
- $a viabilita buněk $x účinky léků $7 D002470
- 650 02
- $a kultivované buňky $7 D002478
- 650 02
- $a lidé $7 D006801
- 650 02
- $a interfáze $x účinky léků $7 D007399
- 650 02
- $a mezenchymální kmenové buňky $x patologie $x účinky léků $7 D059630
- 650 02
- $a methotrexát $x aplikace a dávkování $x chemie $7 D008727
- 655 _2
- $a práce podpořená grantem $7 D013485
- 700 1_
- $a Soukup, Tomáš, $d 1980- $7 xx0036274
- 700 1_
- $a Hroch, Miloš, $d 1976- $7 xx0076212
- 700 1_
- $a Fuksa, Leoš. $7 _BN001818
- 700 1_
- $a Doleželová, Eva. $7 xx0179807
- 700 1_
- $a Cermanová, Jolana, $d 1965- $7 xx0076211
- 700 1_
- $a Kolouchová, Gabriela. $7 _BN005219
- 700 1_
- $a Urban, Karel, $d 1943- $7 skuk0005685
- 700 1_
- $a Mokrý, Jaroslav, $d 1964- $7 jn20000620235
- 700 1_
- $a Mičuda, Stanislav, $d 1972- $7 jn20010309083
- 773 0_
- $t International Orthopaedics $p Int Orthop $g Roč. 34, č. 1 (2010), s. 137-142 $w MED00002384 $x 0946-1965
- 773 0_
- $p Int Orthop $g 34(1):137-42, 2010 Feb
- 910 __
- $a ABA008 $b x $y 4
- 990 __
- $a 20120319124601 $b ABA008
- 991 __
- $a 20121031151923 $b ABA008
- 999 __
- $a ok $b bmc $g 901987 $s 765537
- BAS __
- $a 3
- BMC __
- $a 2010 $b 34 $c 1 $d 137-142 $m International orthopaedics $x MED00002384
- LZP __
- $a 2012-1Q10/